CVS Health Corporation (CVS): Price and Financial Metrics
CVS Health Corporation (CVS)
Today's Latest Price: $57.32 USD
Updated Sep 25 7:00pm
Add CVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 4 in Medical - Drug Stores
See all "A" rated Strong Buy stocks
CVS Stock Summary
- CVS has a market capitalization of $75,014,881,754 -- more than approximately 97.54% of US stocks.
- CVS's went public 34.76 years ago, making it older than 92.87% of listed US stocks we're tracking.
- In terms of volatility of its share price, CVS is more volatile than only 3.97% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to CVS HEALTH Corp, a group of peers worth examining would be ANTM, MDLZ, SHW, TGT, and BKNG.
- Visit CVS's SEC page to see the company's official filings. To visit the company's web site, go to www.cvshealth.com.
CVS Stock Price Chart Technical Analysis Charts
CVS Price/Volume Stats
| Current price | $57.32 | 52-week high | $77.03 |
| Prev. close | $56.71 | 52-week low | $52.04 |
| Day low | $56.11 | Volume | 4,911,411 |
| Day high | $57.43 | Avg. volume | 8,887,099 |
| 50-day MA | $62.15 | Dividend yield | 3.49% |
| 200-day MA | $64.76 | Market Cap | 75.01B |
CVS Health Corporation (CVS) Company Bio
CVS Health Corporation provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The company was founded in 1892 and is based in Woonsocket, Rhode Island.
CVS Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $57.32 | $354.5 | 525% |
We started the process of determining a valid price forecast for CVS HEALTH Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that CVS HEALTH Corp ranked in the 78th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 528%. In terms of the factors that were most noteworthy in this DCF analysis for CVS, they are:
- As a business, CVS is generating more cash flow than 96.55% of positive cash flow stocks in the Healthcare.
- 45% of the company's capital comes from equity, which is greater than only 24.77% of stocks in our cash flow based forecasting set.
- CVS HEALTH Corp's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 1.35% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 513% |
| 1% | 519% |
| 2% | 525% |
| 3% | 531% |
| 4% | 537% |
| 5% | 543% |
PRSC, AMS, FTLF, TVTY, and LNTH can be thought of as valuation peers to CVS, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...